Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
The International Journal on Drug Policy|May 18, 2010
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infectionScott A McDonald, Sharon J Hutchinson, Sheila M Bird, et al.Addiction (Abingdon, England)|September 20, 2023
A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national dataScott A McDonald, Matthew Hickman, John F Dillon, et al.Plos One|December 29, 2012
The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI)David J McLernon, John F Dillon, Frank M Sullivan, et al.BMJ Open|June 4, 2014
Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohortsDavid J McLernon, Peter T Donnan, Frank M Sullivan, et al.Proteome Science|July 10, 2018
Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.The Lancet Regional Health. Europe|November 14, 2025
Estimating incidence rates of primary infection and reinfection with hepatitis C virus among people who inject drugs in Scotland: a model-based analysis of repeated cross-sectional survey dataScott A McDonald, Norah Palmateer, Andrew McAuley, et al.Frontline Gastroenterology|September 2, 2022
Identification of liver disease: why and howIain Macpherson, Kushala W M Abeysekera, Rebecca Harris, et al.Journal of Viral Hepatitis|November 14, 2018
High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programmeJasmine Schulkind, Brian Stephens, Farsana Ahmad, et al.Proteome Science|February 20, 2018
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.BMJ Open|August 11, 2019
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol studySarah K Inglis, Lewis Jz Beer, Christopher Byrne, et al.Pageof 17